SP

Sunita Pathak

Active Director Director DIN 08567135
DIN 08567135 First appointment Oct 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Sunita Pathak

Data last updated:

Sunita Pathak is a Director at Ossium Lifescience Private Limited (since 2019). The company operates in Trading. Ossium Lifescience Private Limited reported revenue of ₹10 Lakh (FY 2022).

DIN 08567135
Primary Designation Director
Industry Trading
First Appointment 19 Oct 2019
Oldest Company Age 7 yrs
Largest company Ossium Lifescience Private Limited · ₹10 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ossium Lifescience Private Limited U51909JH2019PTC013587
Director19 Oct 20192019₹10 Lakh (FY 2022)Active

Board colleagues of Sunita Pathak

Directorship timeline

Open interactive timeline →
Ossium Lifescience Private Limited
Premium access

Shareholding and investment profile for Sunita Pathak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Pathak

Sunita Pathak currently holds 1 directorship: Ossium Lifescience Private Limited (Director, since 19 Oct 2019, revenue ₹10 Lakh (FY 2022)).

Sunita Pathak was first appointed on 19 Oct 2019 as Director at Ossium Lifescience Private Limited.

The current boards of Sunita Pathak's companies include Gayatri Devi (Ossium Lifescience Private Limited), Vijay Sharma (Ossium Lifescience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available